Picodya is excited to announce a new distribution agreement with Gamidor Diagnostics, a leading provider of innovative diagnostic solutions. With decades of expertise in bringing advanced medical and research technologies to market, Gamidor will play a key role in introducing Picodya’s cutting-edge solutions to the research community, with plans to expand into the broader healthcare sector in the future. This collaboration marks a strategic step in accelerating Picodya’s presence and impact in the industry.
As part of this partnership, Gamidor will initially focus on marketing Picodya’s new E-Matrix platform, a breakthrough solution designed to address researchers’ most pressing challenges in testing. E-Matrix provides unparalleled flexibility and agility, requiring minimal sample and reagent volumes, helping laboratories reduce costs, enhance efficiency, and generate immediate results. The partnership leverages Gamidor’s extensive network to ensure researchers and healthcare providers gain access to next-generation diagnostic capabilities that optimize workflows and accelerate scientific discoveries.
